Experts say the U.S. could speed up COVID-19 testing with inexpensive rapid tests, but companies have been unable to gain FDA authorization.
‘Ludicrous’: Cheap, quick COVID-19 tests have been slow to gain FDA approval, a continuing point of frustration
